Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/Tanezumab> ?p ?o }
Showing triples 1 to 73 of
73
with 100 triples per page.
- Tanezumab abstract "Tanezumab (INN, codenamed RN624) is a monoclonal antibody against nerve growth factor. It was developed by Pfizer as a treatment for pain.In 2009 there was a Phase III trial for knee pain due to osteoarthritis (OA).Another phase III trial for hip pain in OA was halted in June 2010 when some patients needed hip replacement.Tanezumab is undergoing Phase II clinical trials for the treatment of various pain entities, including chronic low back pain, bone cancer pain, and interstitial cystitis.In march of 2012 the Anti-NGF Testing - FDA Committee voted in favor of a continuation of the development of nerve-blocking medications, as long as certain safety precautions were observed.A phase III trial published in 2013 found tanezumab was superior to placebo for painful hip osteoarthritis.".
- Tanezumab atcPrefix "none".
- Tanezumab casNumber "880266-57-9".
- Tanezumab fdaUniiCode "EQL0E9GCX1".
- Tanezumab wikiPageExternalLink results?term=Tanezumab.
- Tanezumab wikiPageID "19842161".
- Tanezumab wikiPageLength "3590".
- Tanezumab wikiPageOutDegree "13".
- Tanezumab wikiPageRevisionID "692565068".
- Tanezumab wikiPageWikiLink Atomic_mass_unit.
- Tanezumab wikiPageWikiLink Cancer_pain.
- Tanezumab wikiPageWikiLink Category:Analgesics.
- Tanezumab wikiPageWikiLink Category:Monoclonal_antibodies.
- Tanezumab wikiPageWikiLink Category:Pfizer_products.
- Tanezumab wikiPageWikiLink Clinical_trial.
- Tanezumab wikiPageWikiLink International_nonproprietary_name.
- Tanezumab wikiPageWikiLink Monoclonal_antibody.
- Tanezumab wikiPageWikiLink Nerve_growth_factor.
- Tanezumab wikiPageWikiLink Osteoarthritis.
- Tanezumab wikiPageWikiLink Pfizer.
- Tanezumab wikiPageWikiLinkText "Tanezumab".
- Tanezumab wikiPageWikiLinkText "tanezumab".
- Tanezumab atcPrefix "none".
- Tanezumab c "6464".
- Tanezumab casNumber "880266".
- Tanezumab chemspiderid "none".
- Tanezumab h "9942".
- Tanezumab mabType "mab".
- Tanezumab molecularWeight "145.4".
- Tanezumab n "1706".
- Tanezumab o "2026".
- Tanezumab s "46".
- Tanezumab source "zu/o".
- Tanezumab synonyms "RN624".
- Tanezumab target Nerve_growth_factor.
- Tanezumab type "mab".
- Tanezumab unii "EQL0E9GCX1".
- Tanezumab verifiedfields "changed".
- Tanezumab verifiedrevid "470477328".
- Tanezumab wikiPageUsesTemplate Template:Analgesic-stub.
- Tanezumab wikiPageUsesTemplate Template:Analgesics.
- Tanezumab wikiPageUsesTemplate Template:Cascite.
- Tanezumab wikiPageUsesTemplate Template:Chemspidercite.
- Tanezumab wikiPageUsesTemplate Template:Drugbankcite.
- Tanezumab wikiPageUsesTemplate Template:Drugbox.
- Tanezumab wikiPageUsesTemplate Template:Fdacite.
- Tanezumab wikiPageUsesTemplate Template:Monoclonal-antibody-stub.
- Tanezumab wikiPageUsesTemplate Template:Monoclonals_for_bone,_musculoskeletal,_circulatory,_and_neurologic_systems.
- Tanezumab wikiPageUsesTemplate Template:Neurotrophinergics.
- Tanezumab wikiPageUsesTemplate Template:Reflist.
- Tanezumab subject Category:Analgesics.
- Tanezumab subject Category:Monoclonal_antibodies.
- Tanezumab subject Category:Pfizer_products.
- Tanezumab hypernym Antibody.
- Tanezumab type ChemicalSubstance.
- Tanezumab type Company.
- Tanezumab type Drug.
- Tanezumab type Analgesic.
- Tanezumab type Antibody.
- Tanezumab type Chemical.
- Tanezumab type Company.
- Tanezumab type Drug.
- Tanezumab type ChemicalObject.
- Tanezumab type Thing.
- Tanezumab type Q8386.
- Tanezumab comment "Tanezumab (INN, codenamed RN624) is a monoclonal antibody against nerve growth factor.".
- Tanezumab label "Tanezumab".
- Tanezumab sameAs Q3980782.
- Tanezumab sameAs Tanezumab.
- Tanezumab sameAs m.04q8_y0.
- Tanezumab sameAs Q3980782.
- Tanezumab wasDerivedFrom Tanezumab?oldid=692565068.
- Tanezumab isPrimaryTopicOf Tanezumab.